首页 › 基金 › SUSQUEHANNA ADVISORS GROUP, INC. › LGND
SUSQUEHANNA ADVISORS GROUP, INC. 对 LGND 的持仓历史
LIGAND PHARMACEUTICALS INC · 医疗保健
SUSQUEHANNA ADVISORS GROUP, INC. 在 Q2 2026 的 13F 申报中披露持有 LGND(LIGAND PHARMACEUTICALS INC)44,600 股,市值约 US$14.1M,约占其申报组合的 0.35%,在其申报持仓中市值排名第 39 位。 SUSQUEHANNA ADVISORS GROUP, INC. 于 Q2 2026 首次申报该持仓。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
SUSQUEHANNA ADVISORS GROUP, INC. 对 LGND 的持仓演变
SUSQUEHANNA ADVISORS GROUP, INC. 于 Q2 2026 首次披露 LGND 持仓:44,600 股(约 US$14.1M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 44.60K | $14.10M | 新进 |
关于 LGND 与 13F 数据
LGND(LIGAND PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 58 只申报持有 LGND,申报仓位最大的包括:CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$150.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 LGND 的基金
- CONGRESS ASSET MANAGEMENT CO 658.56K 股 · $205.71M · Q3 2026
- Chicago Capital, LLC 551.23K 股 · $172.19M · Q3 2026
- Stephens Investment Management Group LLC 475.61K 股 · $150.34M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 270.05K 股 · $85.36M · Q2 2026
- Ranger Investment Management, L.P. 257.60K 股 · $81.42M · Q2 2026
- GW&K Investment Management, LLC 246.88K 股 · $78.04M · Q2 2026
- NEXT CENTURY GROWTH INVESTORS LLC 198.54K 股 · $62.76M · Q2 2026
- ASHFORD CAPITAL MANAGEMENT INC 170.24K 股 · $53.81M · Q2 2026
- Private Capital Management, LLC 166.02K 股 · $52.48M · Q2 2026
- VILLERE ST DENIS J & CO LLC 155.51K 股 · $49.15M · Q2 2026
- Granahan Investment Management, LLC 147.23K 股 · $46.54M · Q2 2026
- Penn Capital Management Company, LLC 100.34K 股 · $31.75M · Q2 2026
更多关于 SUSQUEHANNA ADVISORS GROUP, INC.
常见问题
How long has SUSQUEHANNA ADVISORS GROUP, INC. held LGND?
SUSQUEHANNA ADVISORS GROUP, INC. has disclosed LGND holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is SUSQUEHANNA ADVISORS GROUP, INC.'s current position in LGND?
As of Q2 2026, SUSQUEHANNA ADVISORS GROUP, INC. holds 44.60K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $14.10M, representing 0.35% of its reported portfolio and ranking #39.
Has SUSQUEHANNA ADVISORS GROUP, INC. been buying or selling LGND?
In the latest 13F filing (Q2 2026), SUSQUEHANNA ADVISORS GROUP, INC. newly opened its position in LGND.
Which other funds hold LGND?
Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.